Skip to main content

Table 2 CSF cytokines above LLOD from 106 patients with depression and 106 healthy controls

From: Comparisons of 25 cerebrospinal fluid cytokines in a case–control study of 106 patients with recent-onset depression and 106 individually matched healthy subjects

 

Unit

Depression (N = 106)

Healthy controls (N = 106)

Relative mean difference

(95% CI)

p-values

N > LLOD

Mean (95% CI)

N > LLOD

Mean

(95% CI)

IL-6

10–12 g/mL

106

0.90 (0.81–0.99)

106

0.81 (0.73–0.89)

1.10 (0.93–1.30)

0.276

IL-8

10–12 g/mL

106

17.69 (16.71–18.72)

106

20.40 (19.27–21.59)

1.05 (0.96–1.16)

0.294

IFN-γa

10–12 g/mL

92

0.26 (0.22–0.29)

67

0.16 (0.13–0.18)

1.04 (0.82–1.31)

0.762

IL-1αa,b

10–14 g/mL

13

0.36 (0.05–2.66)

9

0.21 (0.02–1.79)

1.13 (0.18–7.26)

0.899

IL-1βa

10–14 g/mL

18

0.05 (0.01–0.22)

8

0.02 (0.00–0.10)

3.52 (0.92 -13.45)

0.066

IL-2a,b

10–14 g/mL

28

1.11 (0.70–1.76)

15

0.75 (0.43–1.29)

1.49 (0.92–2.41)

0.105

IL-4a,b

10–14 g/mL

69

1.28 (1.12–1.48)

40

0.92 (0.78–1.08)

1.40 (1.14–1.72)

0.001c

IL-5a

10–12 g/mL

71

0.50 (0.42–0.59)

74

0.55 (0.46–0.65)

0.84 (0.64–1.12)

0.236

IL-7a

10–12 g/mL

93

0.56 (0.49–0.63)

99

0.66 (0.59–0.75)

0.90 (0.73–1.12)

0.345

IL-10a

10–14 g/mL

87

8.44 (7.41–9.61)

71

7.11 (6.19–8.16)

1.04 (0.84–1.31)

0.700

IL-12a,d

10–12 g/mL

104

5.19 (4.69–5.74)

105

4.76 (4.30–5.27)

0.98 (0.82–1.16)

0.792

IL-13a

10–12 g/mL

12

1.11 (0.94–1.32)

18

1.20 (1.04–1.39)

0.98 (0.84–1.15)

0.803

IL-15

10–12 g/mL

106

3.13 (2.90–3.37)

106

3.24 (3.01–3.49)

0.95 (0.84–1.08)

0.454

IL-16

10–12 g/mL

106

9.60 (8.75–10.54)

106

11.02 (10.04–12.10)

0.89 (0.76–1.05)

0.164

IL-17Aa,b

10–13 g/mL

15

0.95 (0.27–3.34)

10

0.83 (0.21–3.34)

1.15 (0.40–3.29)

0.795

IP-10a

10–11 g/mL

106

9.08 (8.04–10.24)

105

9.15 (8.11–10.33)

1.15 (0.93–1.41)

0.191

MCP-1a

10–10 g/mL

106

3.38 (3.07–3.73)

105

3.12 (2.83–3.44)

1.25 (1.06–1.47)

0.009e

MCP-4a,b

10–11 g/mL

5

1.35 (0.74–2.46)

2

1.13 (0.54–2.35)

1.20 (0.85–1.70)

0.310

MDCa

10–12 g/mL

94

7.35 (6.61–8.17)

92

7.81 (7.02–8.68)

0.94 (0.78–1.13)

0.497

MIP-1αa

10–12 g/mL

68

2.72 (2.46–3.02)

82

3.53 (3.20–3.90)

0.87 (0.73–1.03)

0.103

MIP-1βa

10–12 g/mL

106

9.54 (8.83–10.31)

105

9.00 (8.33–9.72)

1.16 (1.02–1.33)

0.025e

TARCa

10–12 g/mL

59

1.94 (1.69–2.22)

65

2.18 (1.91–2.49)

1.07 (0.86–1.33)

0.559

TNF-αa

10–13 g/mL

26

1.06 (0.70–1.59)

34

1.36 (0.92–2.02)

0.74 (0.44–1.25)

0.266

TNF-βa

10–14 g/mL

7

0.15 (0.01–2.00)

8

0.29 (0.02–3.34)

0.31 (0.04–2.29)

0.251

ICAM-1

10–9 g/mL

106

1.48 (1.40–1.57)

106

1.41 (1.33–1.50)

1.04 (0.94–1.16)

0.401

  1. Estimated means, relative mean differences, CIs and p-values are based on censored log-normal models adjusted for sex, age and plate
  2. CI confidence interval, CSF cerebrospinal fluid, LLOD lower limit of detection, IFN interferon, IP-10 interferon gamma-induced protein-10, IL interleukin, MCP monocyte chemoattractant protein, MDC macrophage-derived chemokine, MIP macrophage inflammatory protein, TARC thymus- and activation-regulated chemokine, TNF tumor necrosis factor, sICAM soluble intercellular adhesion molecule
  3. aAnalyses included censored measurements
  4. bNot adjusted for plate due to too few measurements above LLOD
  5. cp-value after correction for multiple testing: 0.025
  6. dIL12/23p40
  7. eNot significant after correction for multiple testing